SpaceX sends 27 Starlink satellites into orbit from California
June 4 (UPI) -- SpaceX on Wednesday afternoon launched another batch of 27 Starlink satellites to low-Earth orbit from Vandenberg Space Force Base in California on the 15th anniversary of the first Falcon 9 rocket launch.
It was the 500th orbital launch of a Falcon rocket, including Falcon 1, Falcon 9 and Falcon Heavy, Spaceflight Now reported.
The Falcon 9 lifted off from pad 4E at 4:40 p.m. PDT.
A little more than eight minutes after liftoff, the first stage landed on the "Of Course I Still Love You" droneship in the Pacific Ocean.
This was the 26th flight for the first stage booster, which included 18 Starlink missions.
It was thge 134th landing on this vessel and the 457th booster landing in California and Florida.
The first launch of a Falcon 9 rocket was on June 4, 2010, from Cape Canaveral Space Launch Complex pad 40. This was a test Dragon spacecraft successfully placed into orbit.
In 2020, Falcon 9 was the first commercial rocket to launch humans to orbit.
Falcon has sent commercial resupply missions, including astronauts, to the International Space Station.
The next SpaceX Falcon 9 launch is scheduled for 11:19 p.m. EDT Friday from Cape Canaveral Space Force Station pad 40. The rocket will launch a geostationary satellite for SiriusXM.
Private mission to ISS
SpaceX, NASA and Axiom Space are planning a launch of the fourth private astronaut mission to the International Space Station, Axiom Mission 4, for 8:22 p.m. Tuesday from the Kennedy Space Center's pade 39A.
The Falcon 9 rocket is scheduled to launch a new SpaceX Dragon spacecraft. The targeted docking time is approximately 12:30 p.m., June 11. There are nine people currently on the ISS.
Axiom Space and SpaceX are planning coverage to start at 6:15 a.m. and NASA at 7:25 a.m.
Peggy Whitson, a former NASA astronaut and director of human spaceflight at Axiom Space, will command the commercial mission. She is 65 years old.
The crew also includes pilot Shubhanshu Shukla with the Indian Space Research Organization, and mission specialists with the European Space Agency, Sławosz Uznański-Wiśniewski of Poland and Tibor Kapu of Hungary.
This would be the first time ISRA will send an astronaut to the space station as well as ESA astronauts from Hungary and Poland.
NASA and the Indian agency are planning five joint science investigations and two in-orbit science, technology, engineering and mathematics demonstrations.
Axiom Space, which is based in Houston and founded in 2016, is building the first commercial space station with deployment planned in the late 2020s.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Insider
28 minutes ago
- Business Insider
Opening Day: Stablecoin issuer Circle soars in public debut
Shares of Circle jumped almost 170% in their trading debut after the stablecoin company raised about $1.1B in its IPO. The stock opened at $69 after the pure-play crypto company priced its initial public offering at $31 per share. Confident Investing Starts Here: Two other big names are next, with IPOs expected next week. Fintech Chime and space and defense company Voyager Technologies are expected to go public sometime in the week of June 9. Omada Health (OMDA) opened on June 6 at $23. The company that bills itself as 'the virtual between-visit healthcare provider' priced 7.9M shares at $19.00, in the middle of the $18.00-$20.00 range. Circle (CRCL) opened on June 5 at $69.00. The company priced its upsized initial public offering of 34M shares at a public offering price of $31.00 per share. Circle is a financial technology firm that enables businesses 'to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide.' END OF THE WEEK PERFORMANCE: Omada Health – up almost 31% at $24.80. Circle – up about 42% at $117.25. RECENT IPOS TO WATCH: Arrive AI (ARAI), eToro (ETOR), Antalpha (ANTA), and OMS Energy (OMSE) are among stocks that could see new coverage roll out this upcoming week as the quiet periods for banks that underwrote the companies' IPOs expire. Click here to see upcoming IPO calendar on TipRanks. Voyager Technologies filed with the SEC for an initial public offering of shares of Class A common stock. The company said it intends to apply to list its Class A common stock on the New York Stock Exchange under the symbol 'VOYG.' The prospectus states, 'We are an innovation-driven defense technology and space solutions company. Our company was purpose-built to address issues at the forefront of defense, national security and space industries and we have organized our business to reflect this goal. We strive to solve complex challenges to fortify national security, protect critical assets and unlock new frontiers for human progress and economic development. We are committed to developing and delivering an array of transformative, mission-critical solutions to customers enabled by our advanced technology, analytics and space infrastructure capabilities. Our solutions include communications and intelligence collection systems, defense systems, advanced space technology, in-space infrastructure and space mission services. Our business consists of diversified solutions across three business segments: Defense & National Security, Space Solutions and Starlab Space Stations. Since 2019, we have accomplished significant achievements in each of these segments, including the successful deployment of first-of-its-kind missile defense maneuvering capabilities, the development of groundbreaking space technology and the selection by NASA to develop a replacement for the ISS… Since 2019, we have executed and successfully vertically and horizontally integrated seven acquisitions, and have grown our revenue to $144.2 million in 2024 and $34.5 million for the three months ended March 31, 2025.' Strategy (MSTR) announced that, subject to market and other conditions, it intends to conduct an initial public offering registered under the Securities Act of 1933, as amended, of 2.5M shares of Strategy's 10.00% Series A Perpetual Stride Preferred Stock, the ' STRD Stock.' Strategy intends to use the net proceeds from the offering for general corporate purposes, including the acquisition of bitcoin and for working capital. Fitness Champs filed an initial public offering of 2M ordinary shares, with selling shareholders offering an additional 1.75M shares. The company intends to apply to list its shares on the Nasdaq under the symbol 'FCHL.' The company anticipates the initial public offering price will be between $4.00-$5.00 per share. Bancroft Capital is acting as the underwriter. Chime announced that it has filed a registration statement with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock. Chime has applied to list its common stock on the Nasdaq under the ticker symbol 'CHYM.' The number of shares to be offered and the price range for the proposed offering have not yet been determined. Morgan Stanley, Goldman Sachs and J.P. Morgan will act as lead book-running managers for the proposed offering. Barclays will act as an additional book-running manager. Evercore ISI, UBS Investment Bank, Deutsche Bank Securities, Piper Sandler and Wolfe Nomura Alliance will act as bookrunners. William Blair, Canaccord Genuity, Keefe, Bruyette & Woods, First Citizens Capital Securities and Texas Capital Securities will act as co-managers. Chime is a financial technology company. Happy City filed with the SEC for an initial public offering of 1M Class A ordinary shares of Happy City Holdings Limited, representing 14.29% of the Class A ordinary shares following completion of the offering. The company expects the initial public offering price will be between $5.00 and $7.00 per Class A share and notes it has reserved the symbol 'HCHL' for purpose of listing its Class A ordinary shares on the Nasdaq Capital Market. Odyssey Therapeutics has filed with the SEC for an initial public offering of shares of common stock. The company has applied to list its common stock on the Nasdaq Capital Market under the trading symbol 'ODTX.' The prospectus filed with the SEC states, 'Odyssey is a clinical-stage biopharmaceutical company led by a team and board of drug hunters seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases… Our most advanced programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, for which we intend to commence a Phase 2a monotherapy trial for ulcerative colitis, or UC, in the first quarter of 2025 and a Phase 2a combination trial with vedolizumab in the first half of 2026, and two preclinical programs: a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.' OTHER IPO NEWS: Dubai party hotel operator FIVE Holdings is considering listing in London or New York, three people with knowledge of the matter said, Reuters' Hadeel Al Sayegh and Federico Maccioni report. The company, which owns the Pacha hotel and nightclub, has been exploring an initial public offering in Dubai, it has said. Chairman and founder Kabir Mulchandani said last year the company was worth up to $3B and was considering a dual listing. He did not name possible locations, the authors note.
Yahoo
44 minutes ago
- Yahoo
Trump-Musk showdown threatens US space plans
SpaceX's rockets ferry US astronauts to the International Space Station. Its Starlink satellite constellation blankets the globe with broadband, and the company is embedded in some of the Pentagon's most sensitive projects, including tracking hypersonic missiles. So when President Donald Trump threatened on Thursday to cancel Elon Musk's federal contracts, space watchers snapped to attention. Musk, the world's richest person, shot back that he would mothball Dragon -- the capsule NASA relies on for crew flights -- before retracting the threat a few hours later. For now, experts say mutual dependence should keep a full-blown rupture at bay, but the episode exposes just how disruptive any break could be. Founded in 2002, SpaceX leapfrogged legacy contractors to become the world's dominant launch provider. Driven by Musk's ambition to make humanity multiplanetary, it is now NASA's sole means of sending astronauts to the ISS -- a symbol of post–Cold War cooperation and a testbed for deeper space missions. - Space monopoly? - The company has completed 10 regular crew rotations to the orbiting lab and is contracted for four more, under a deal worth nearly $5 billion. That's just part of a broader portfolio that includes $4 billion from NASA for developing Starship, the next-generation megarocket; nearly $6 billion from the Space Force for launch services; and a reported $1.8 billion for Starshield, a classified spy satellite network. Were Dragon grounded, the United States would again be forced to rely on Russian Soyuz rockets for ISS access -- as it did between 2011 and 2020, following the Space Shuttle's retirement and before Crew Dragon entered service. "Under the current geopolitical climate, that would not be optimal," space analyst Laura Forczyk told AFP. NASA had hoped Boeing's Starliner would provide redundancy, but persistent delays -- and a failed crewed test last year -- have kept it grounded. Even Northrop Grumman's cargo missions now rely on SpaceX's Falcon 9, the workhorse of its rocket fleet. The situation also casts a shadow over NASA's Artemis program. A lunar lander variant of Starship is slated for Artemis III and IV, the next US crewed Moon missions. If Starship were sidelined, rival Blue Origin could benefit -- but the timeline would almost certainly slip, giving China, which aims to land humans by 2030, a chance to get there first, Forczyk warned. "There are very few launch vehicles as capable as Falcon 9 -- it isn't feasible to walk away as easily as President Trump might assume," she said. NASA meanwhile appeared eager to show that it had options. "NASA is assessing the earliest potential for a Starliner flight to the International Space Station in early 2026, pending system certification and resolution of Starliner's technical issues," the agency said in a statement Friday to AFP. Still, the feud could sour Trump on space altogether, Forczyk cautioned, complicating NASA's long-term plans. SpaceX isn't entirely dependent on the US government. Starlink subscriptions and commercial launches account for a significant share of its revenue, and the company also flies private missions. The next, with partner Axiom Space, will carry astronauts from India, Poland, and Hungary, funded by their respective governments. - Private power, public risk - But losing US government contracts would still be a major blow. "It's such a doomsday scenario for both parties that it's hard to envision how US space efforts would fill the gap," Clayton Swope, deputy director of the Aerospace Security Project at the Center for Strategic and International Studies, told AFP. "Both sides have every reason to bridge the disagreement and get back to business." Signs of a rift emerged last weekend, when the White House abruptly withdrew its nomination of e-payments billionaire Jared Isaacman -- a close Musk ally who has twice flown to space with SpaceX -- as NASA administrator. On a recent podcast, Isaacman said he believed he was dropped because "some people had some axes to grind, and I was a good, visible target." The broader episode could also reignite debate over Washington's reliance on commercial partners, particularly when one company holds such a dominant position. Swope noted that while the US government has long favored buying services from industry, military leaders tend to prefer owning the systems they depend on. "This is just another data point that might bolster the case for why it can be risky," he said. "I think that seed has been planted in a lot of people's minds -- that it might not be worth the trust." ia/dw/nl/acb Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Departure of Tesla's humanoid robot boss caps tough week for Elon Musk, amid bitter fallout with Trump
It's been a difficult week for Tesla. Not long after Elon Musk and President Donald Trump's very-public social media spat led Tesla shares to take their greatest single-day drop ever on Thursday—erasing $152 billion off its market cap—one of Tesla's top engineers confirmed on social media late Friday afternoon that he was leaving the company. Milan Kovac, who oversaw the development of Tesla's 'Optimus' humanoid robot posted on X that he had made 'the most difficult decision of my life' and would be 'moving out of my position,' confirming a Bloomberg report from earlier Friday afternoon that he was departing the company. 'I've been far away from home for too long, and will need to spend more time with family abroad,' he wrote in the post. 'I want to make it clear that this is the only reason, and has absolutely nothing to do with anything else. My support for [Elon Musk] and the team is ironclad—Tesla team forever.' Musk later replied to the post on X, thanking Kovac for his contributions to the company and saying it had been an 'honor' to work with him. The departure is a meaningful one for Tesla. Musk has repeatedly made public statements staking the future of the company on Tesla's self-driving software and its yet-to-be-released humanoid robot product. Musk has claimed that the Optimus robot, specifically, could generate 'north of $10 trillion in revenue' for Tesla and be its biggest product ever. It's largely his bullishness on these AI-powered initiatives that have contributed to Tesla's soaring stock price, which some analysts have argued is divorced from reality. Kovac's departure raises questions over the future direction of Optimus, and whether Tesla will successfully be able to develop, manufacture, and deliver the humanoid robots. Bloomberg reported that Ashok Elluswamy, who leads Tesla's Autopilot, would be taking over responsibilities for Optimus. Tesla had already been criticized for overselling the capabilities of Optimus after it failed to alert attendees of its 'We, Robot' launch event that humans were apparently remotely controlling the robots. (Kovac had confirmed in a social media post after the event that the robots were human-assisted 'to some extent') The departure of one of Tesla's top engineers adds to what has already been a troubling week for the electric vehicle maker. Tesla's shares tumbled this week as President Trump and Musk took to their respective social media platforms to hurl insults at one another. Trump accused Musk of being frustrated that EV credits for Tesla cars would go away as part of the 'Big Beautiful Bill,' while Musk accused the president of irresponsible spending with the proposed legislation. The conversation spiraled into insults and even discussions of cutting SpaceX contracts with NASA as the partnership between the two figures very publicly imploded. Adding to Tesla's woes, Wall Street investment bank Goldman Sachs issued a note to investors on Thursday forecasting weaker-than-expected sales of Tesla cars in the second quarter. Tesla shares recovered some ground on Friday as Musk said he was open to making amends with Trump, though the stock still finished the week down 14% from January (still, Tesla shares are trading nearly 66% higher than they were this time last year.) In his social media post, Kovac recounted how he had joined Tesla in 2016 as an engineer on its Autopilot team and that he had transitioned to lead the Optimus group in early 2022 when Tesla had 'nothing but a couple Kuka arms arranged upside-down,' referring to the industrial robotic arms that are often used in automated factory systems. Tesla did not respond to an immediate request for comment on Kovac's departure. This story was originally featured on